Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 196.08

-0.2%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Henry Niman who wrote (12903)	12/31/1997 9:37:00 PM
From: Andrew H	Read Replies (1) of 32384

You are probably right, but I checked the prnewswire releases for Targretin info on head and neck cancer and found nothing--then I went to the clinical trials site and found no listing of trials for head and neck cancers under Targretin. I thought that I had read that Targretin was in trials for squamous cell cancer, but since I could find nothing in print, I assumed it was 1550. If P1s were initiated in 1994, we certainly would have seen some results by now. Have there been any releases on these trials? Just saw in the molecule of the month article they mentioned Targretin was in P 11b for head and neck cancer in Dec. of 1996. Seems like we should have heard something by now. Once again, happy New Year!!! Guess we should be seeing the results on the 1550 trials soon.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next